Company profile
Home - Ablatus Therapeutics
Ablatus Therapeutics Limited is a UK company with status active founded in 2015 based in Yorkshire and the Humber.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
AD01 | Transaction MzQzODI5MjEwNGFkaXF6a2N4 | Paper/PDF filed
Published 09 Oct 2024 06:29
LIQ02 | Transaction MzQzODI5MTg2MWFkaXF6a2N4 | Paper/PDF filed
Published 08 Oct 2024 06:39
600 | Transaction MzQzODI5MTYxNGFkaXF6a2N4 | Paper/PDF filed
Published 08 Oct 2024 06:38
RESOLUTIONS | Transaction WURDWEJCS0FhZGlxemtjeA | Paper/PDF filed
Published 08 Oct 2024 06:35
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Aug 2020 to 31 Jul 2022
Colorectal cancer is the second most common cause of cancer-related deaths in Europe and North America, after lung cancer (Jemal et al., 2007). In the UK, approximately 34,500 new cases of colorectal cancer and 16,200 deaths were registered in 2001 (Cancer Research UK, 2005). This equates to 1 death in the UK from colorectal cancer every 32 minutes. About...
1 Sep 2017 to 31 May 2019
BETA is the next generation of radiofrequency ablation medical device, providing a minimally invasive method for destroying cancerous tissue. It will revolutionise the approach to non-resectable liver metastases, allowing for the non-invasive treatment of large volume with low recurrence risk within patients. BETA is the result of 10 years of academic res...
